ID
24755
Beskrivning
Study ID: 100470 Clinical Study ID: SCO100470 Study Title: A multicentre, randomised, double-blind, parallel group, 24 week study to compare the effect of salmeterol/fluticasone propionate combination product 50/250mcg, with salmeterol 50mcg both delivered twice daily via DISKUS®/ACCUHALER® inhaler on lung function and dyspnoea in subjects with Chronic Obstructive Pulmonary Disease (COPD). Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: N/A Sponsor:GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: fluticasone propionate/salmeterol Trade Name: Serevent Study Indication: Pulmonary Disease, Chronic Obstructive
Nyckelord
Versioner (1)
- 2017-08-16 2017-08-16 -
Rättsinnehavare
GlaxoSmithKline
Uppladdad den
16 augusti 2017
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
transition dyspnoea index salmeterol/fluticasone propionate combination compared to salmeterol on COPD 100470
transition dyspnoea index salmeterol/fluticasone propionate combination compared to salmeterol on COPD 100470
Beskrivning
TRANSITION DYSPNOEA INDEX (TDI)
Alias
- UMLS CUI-1
- C3714807 (Transition Dyspnea Index Questionnaire)
Beskrivning
date of assessment
Datatyp
date
Alias
- UMLS CUI [1]
- C2985720 (Assessment Date)
Beskrivning
visit description
Datatyp
text
Alias
- UMLS CUI [1,1]
- C0545082 (Visit)
- UMLS CUI [1,2]
- C0678257 (Description)
- LOINC
- LP6800-9
Beskrivning
transition dyspnoea index
Datatyp
integer
Alias
- UMLS CUI [1]
- C3714807 (Transition Dyspnea Index Questionnaire)
Inga kommentarer